Thompson Lab

June 1, 2023

Aspen symposium takes on question of medical uses for psychedelics now that it’s legal

Dr. Scott Thompson, a neuroscientist at the University of Colorado School of Medicine Department of Psychiatry, joins this year's panel to discuss his recent shift from studying depression in mice to the first modern-era Colorado psilocybin clinical trial.

Aspen Psychedelic Symposium: The Neuroscience of Psychedelics

Aspen Public Radio

June 15, 2023

Aspen Psychedelic Symposium: The Neuroscience of Psychedelics

Dr. Scott Thompson, a neuroscientist at the University of Colorado of Medicine Department of Psychiatry joins this year's panel to discuss his recent shift from studying depression in mice to the first modern-era Colorado psilocybin clinical trial.

Can Ketamine stop suicides? A neuroscientist's perspective

Knowable Magazine

March 29, 2019

Can Ketamine stop suicides? A neuroscientist's perspective

Scott Thompson (University of Maryland, School of Medicine) discusses the current evidence for ketamine as a psychiatric treatment for severe depression, the unknown risks of long-term use and both the promises and risks of the esketamine nasal spray